bifidobacterium pseudocatenulatum strain, combination of microorganism, cellular components, metabolites, secreted molecules or any combination thereof, composition, use of a species b strain. pseudocatenulatum, use of lineage, combination of microorganism, cellular metabolite components, secreted molecules or any combination thereof or composition
The present invention relates to the Bifidobacterium CECT 7765 strain, to its cell components, metabolites, and secreted molecules, to the combinations thereof with other microorganisms, and to compositions comprising the aforementioned products, as well as to the use of a strain of the Bifidobacterium pseudocatenulatum species, or to using the CECT 7765 strain for the prevention and/or treatment of obesity, overweight, hyperglycemia and diabetes, preferably type 2 diabetes mellitus, hepatic steatosis or fatty liver, dyslipidemia, metabolic syndrome, immune system dysfunction associated with obesity and overweight； and an unbalanced composition of the intestinal microbiota associated with obesity and overweight.
